Panning the Golden Batch
Like an Olympian combining many precise steps on the journey to a gold medal, a bioprocessor develops a plan that turns substances from living cells into a therapy that raises…
Is Biopharma Ready for AI? Exploring Tech Strategies Across Large and Small Biopharma
Biopharma companies face unique challenges in scaling AI-and those challenges vary greatly depending on whether you’re at a small or large biopharma. While large biopharma is pushing ahead with nearly…
AI Drug Discovery Dataset Tops 100M Cells in Vevo, Parse Partnership
A collaboration between Parse Biosciences’ GigaLab and Vevo Therapeutics has generated what they say is the largest single-cell dataset to date. The Tahoe-100M dataset comprises 100 million cells and covers…
AI Approach Builds Genomenon’s Database of Clinically Relevant Genomic Data
As the amount of genomic data grows, so too does the challenge of organizing it into a usable database. Indeed, the lack of a searchable database of genomic information from…